SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-14-001061
Filing Date
2014-04-04
Accepted
2014-04-04 17:18:20
Documents
8
Period of Report
2014-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1400598_8k.htm 8-K 21221
2 EXHIBIT 1.1 t1400598_ex1-1.htm EX-1.1 215257
3 EXHIBIT 5.1 t1400598_ex5-1.htm EX-5.1 10665
4 EXHIBIT 99.1 t1400598_ex99-1.htm EX-99.1 12037
5 EXHIBIT 99.2 t1400598_ex99-2.htm EX-99.2 12397
6 GRAPHIC image_001.jpg GRAPHIC 6083
7 GRAPHIC image_002.jpg GRAPHIC 4277
8 GRAPHIC image_003.jpg GRAPHIC 5489
  Complete submission text file 0001571049-14-001061.txt   295118
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 14746805
SIC: 2834 Pharmaceutical Preparations